Related Experiment Video
Updated: Aug 16, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Euro heart failure survey. Medical treatment not in line with current guidelines
K Drechsler1, R Dietz, H Klein
1Universität Leipzig-Herzzentrum, Leipzig, Germany.
Insights
Heart failure patients in Germany are not receiving guideline-recommended treatments, including ACE inhibitors and beta-blockers. Physician awareness of best practices for heart failure management needs improvement to enhance patient outcomes.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Heart failure is a significant cause of morbidity and mortality.
- Current guidelines recommend specific medical therapies to improve outcomes.
- Assessing adherence to these guidelines is crucial for patient care.
Purpose of the Study:
- To evaluate the adherence to current heart failure treatment guidelines in German patients.
- To identify potential gaps in medical therapy prescription and dosage.
Main Methods:
- The Euro Heart Survey on Heart Failure screened patients in 7 German medical centers.
- Inclusion criteria included diagnoses of myocardial infarction, atrial fibrillation, or diabetes mellitus, plus specific heart failure indicators.
- Data on patient demographics, diagnoses, and prescribed medications were collected.
Main Results:
- 747 patients with heart failure were included in the study, with 93% suffering from the condition.
- Despite high rates of ischemic heart failure (71%), only 72% received ACE inhibitors and 62% received beta-blockers.
- Recommended dosages were met by only 63% of ACE inhibitor users and 54% of beta-blocker users. Diuretics were used in 74% of patients.
Conclusions:
- A significant number of heart failure patients are undertreated according to established guidelines.
- There is a need to improve physician awareness and implementation of evidence-based heart failure therapies.
- Optimizing medical management could lead to improved patient morbidity and mortality.
Unlabelled:
It was the aim of the Euro Heart Survey on Heart Failure to assess whether patients are being treated according to current guidelines.
Methods:
In Germany, patients were screened in 7 medical centers if their discharge diagnoses were myocardial infarction, a new episode of atrial fibrillation, or diabetes mellitus. Patients were enrolled if at least one additional criterion was fulfilled: (1) clinical diagnosis of heart failure, (2) hospital admission due to heart failure within the last 3 years, (3) therapy with loop diuretic, (4) medication for heart failure or ventricular dysfunction documented by echocardiography within the past 24 hours prior to death.
Results:
2166 patients were screened of whom 747 were included in the study (478 men, 269 women). 93% of the patients suffered from heart failure. Despite the high number of patients with known heart failure (ischemic heart failure in 71%), only 72% received ACE inhibitors and 62% beta-blockers. Average daily dose met recommendations in only 63% of patients on ACE inhibitors and 54% on beta-blockers. 74% of the patients received diuretics (furosemide 36%, thiazide 34%, spironolactone 17%).
Conclusion:
An inadequately low number of patients with heart failure receives medical therapy according to guidelines, despite all the overwhelming evidence for improved morbidity and mortality. Awareness of physicians needs to be improved.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy V: Interprofessional Care
